Zynerba Pharmaceuticals

$ZYNE is leading the Prism MarketView Cannabis Index and is up nearly 300% on news of its acquisition by Harmony Bio

Share This Article

 

About the Author

Zynerba Pharmaceuticals

Joey Ramson